Itano, Seiji http://orcid.org/0000-0002-9452-4117
Kanda, Eiichiro
Nagasu, Hajime
Nangaku, Masaomi
Kashihara, Naoki
Funding for this research was provided by:
Japan Agency for Medical Research and Development (22mk0101172h0003)
Article History
Received: 28 March 2023
Accepted: 2 July 2023
First Online: 19 July 2023
Declarations
:
: The contributing authors reported the following financial supports: Seiji Itano, Eiichiro Kanda, and Hajime Nagasu have nothing to declare regarding potential conflicts of interest relevant to this article. Masaomi Nangaku has received lecture fees from Kyowa Kirin Co., Ltd., Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation, Bayer Yakuhin, Ltd., and Japan Tobacco Inc.; fee for writing manuscript from Kyowa Kirin Co., Ltd.; research funds from EPS Corporation, Parexel International Inc., and Japan Tobacco Inc.; and research grants from Kyowa Kirin Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Chugai Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd., and Daiichi Sankyo Co., Ltd. Naoki Kashihara has received lecture fees from Daiichi Sankyo Co., Ltd., AstraZeneca K.K., Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd, Astellas Pharma Inc., Kyowa Kirin Co., Ltd., Bayer Yakuhin, Ltd., Nobelpharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Novartis Pharma K.K.; research funds from AstraZeneca K.K., Nobelpharma Co., Ltd., Daiichi Sankyo Co., Ltd., and Bayer Yakuhin, Ltd.; and research grants from Chugai Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Ono Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Astellas Pharma Inc., Otsuka Pharmaceutical Co., Ltd., and Boehringer Ingelheim GmbH.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee of Kawasaki Medical School and Kawasaki Medical School Hospitals (IRB approval number 5609–00) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. In accordance with the clinical research act in enacted by Ministry of Health, Labour and Welfare of Japan (Clinical Trials Act (Act No. 16 of April 14, 2017), Ministry of Health, Labour and Welfare (MHLW). ExternalRef removed. Accessed 1 March 2023.), since it is difficult to obtain written or oral informed consent from the study participants, and database information was provided in a completely anonymized form, the investigators were not required to obtain consent.